Chimeric antigen receptor (CAR) T-cell therapy has shown impressive efficacy in treating relapsed or refractory multiple myeloma. Nonetheless, its availability is substantially restricted by complex ...

LONDON: British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States ...